USD10
BBOT Shares
About BridgeBio OncologyBridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
USD10
BBOT Shares
About BridgeBio OncologyBridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$705.89M
OPEN PRICE
$9.23
LOW (1Y)
$8.50
HIGH (1Y)
$14.87
LOW (24H)
$8.86
HIGH (24H)
$9.36
VOLUME (24H)
$143.75K
108.63%
Price history
Time | Price | Change |
|---|---|---|
Today | $9.23 | |
1 Day | $9.12 | |
1 Week | $8.76 | |
1 Month | $10.00 | |
1 Year | $11.30 |
Past performance is not a reliable indicator of future results.
Discover more
Popular cryptocurrencies
Popular prediction markets
Popular price predictions
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
